Skip to main content
Frontiers in Pediatrics logoLink to Frontiers in Pediatrics
. 2020 Dec 11;8:575673. doi: 10.3389/fped.2020.575673

Case Report: A de novo CTNNB1 Nonsense Mutation Associated With Neurodevelopmental Disorder, Retinal Detachment, Polydactyly

Zhongling KE 1, Yanhui CHEN 1,*
PMCID: PMC7793974  PMID: 33425807

Abstract

CTNNB1 gene mutation was firstly reported related to intellectual disability in 2012, to explore the clinical phenotype and genotype characteristics of CTNNB1 mutation, we collected and analyzed the clinical data of a child with a neurodevelopmental disorder caused by a mutation of CTNNB1. The child had dysmorphic features, microcephaly, hypotonia, polydactyly, retinal detachment, and neurodevelopmental disorder, with a de novo mutation of CTNNB1 c.1603C > T, p.R535X. The patient was diagnosed as Neurodevelopmental disorder with spastic diplegia and visual defects (NEDSDV) and was given rehabilitation training. After 4 months of rehabilitation training, she improved in gross motor function. We found that CTNNB1 mutation can cause neurodevelopmental disorder, which could be accompanied by retinal detachment and polydactyly. The retinal detachment had only been reported in two Asian patients, and we firstly reported the phenotype of polydactyly in the CTNNB1 mutation. This report not only helps to expand the clinical phenotype spectrum of the CTNNB1 gene mutation but also prompts a new insight into genetic diagnosis in patients with a neurodevelopmental disorder, retinal detachment, and polydactyly.

Keywords: CTNNB1 gene, neurodevolpmental disorder, retinal detachment, polydactyly, case report

Introduction

CTNNB1 (OMIM: 116806) gene encodes β–catenin protein, which is an integral part of the cadherin/catenin complex and is related to the activation of the Wnt signaling pathway.

It found that β–Catenin knockout mice showed the same behavior as autism spectrum disorder (1), while the loss of function of the CTNNB1 gene was related to intelligence disorder (2). CTNNB1 gene mutations have a variety of phenotypes, such as Colorectal cancer, Exudative vitreoretinopathy 7, Hepatocellular carcinoma, Medulloblastoma, Neurodevelopmental disorder with spastic diplegia and visual defects and Pilomatricoma (3). Neurodevelopmental disorder with spastic diplegia and visual defects(NEDSDV, OMIM:615075) was the only one presenting neurological impairment, which was characterized by global developmental delay, impaired intellectual development, axial hypotonia, and dysmorphic craniofacial features with microcephaly. Many patients have visual abnormalities, ranging from strabismus to optic nerve atrophy and retinal abnormalities. Spasticity may also occur in the affected individuals, particularly of the lower extremities, and may have behavioral abnormalities (4).

At present, 33 cases of the disease have been reported in the world (2, 511), with only two in Asia (8, 10). This paper reports the clinical characteristics and genetic analysis of the third case of neurodevelopmental disorder caused by CTNNB1 gene mutation in the Asian population, and we found that polydactyly may be a new feature of CTNNB1 mutation.

Case Report

The patient was a 15-month-old girl who came to our department developmental retardation. She is the second child of Chinese parents who are both healthy, young, non-consanguineous. She has a healthy elder brother. During pregnancy, ultrasound scan showed intrauterine growth retardation. She weighed 2.35 kg at birth. The family history was negative for birth defects, developmental delay, intellectual delay, and/or any other neurological disorders.

After a normal neonatal period, she was found with motor retardation when she can't raise her head at 3 months old. At the age of 4 months, she had an ophthalmologic examination and was found blindness in the left eye when her parents wanted to treat strabismus her left eye. Ultrasonic examination showed a retinal detachment in the left eye. Fortunately, her right eye was normal. The patient was evaluated in our department at 15 months. She can raise her head but unstably, and still can't sit. The language barrier is very serious. She can make some sounds, but she can't speak. er parents found her intelligence lower than her peers. Physical examination showed as follows: weight 7.5 kg (−2.46 SD), height 72.5 cm(−2.29 SD), occipitofrontal circumference(OFC) 41 cm (−4.17 SD), anterior frontal was closure, light hair color, fair skin, low set ears, flat nasal bridge, strabismus in the left eye, thin upper lip, polydactyly in the right hand, but the foot does not have polydactylous. The systolic murmur of grade 2/6 can be heard in the 3–4 intercostals of the precordial area. The lung and abdomen are normal. The tension of trunk and peripheral limbs decreased significantly. Bilateral tendon reflexes were weakened, Babbitt's sign was negative, and no sign of spastic paralysis (Figures 1A–E). Auxiliary examination: the whole blood count, urine routine test, biochemical test, thyroid function, and the level of 25 (OH) D3 were all normal. Color Doppler echocardiography showed atrial septal defect, right heart enlargement, pulmonary hypertension, and tricuspid regurgitation (Table 1).

Figure 1.

Figure 1

(A,B) Craniofacial dysmorphism; (C) microcephaly; (D) polydactyly; (E) Hypotonia.

Table 1.

Clinical findings in our patient and patients reported (4) before with the same mutation.

Our patient Patient 1 Patient 2
Gender Female Male Male
Gestational weeks 38 40 41
Birth weight (kg) 2.35 3.05 3.4
Maternal age 24 39 28
Paternal age 26 43 38
Age of onset of symptoms Birth 3 months Birth
Age at diagnosis 1 year 3 months 3 years 3 months 14 years
Prenatal issues Intrauterine growth retardation None None
Neonatal issues None Low oxygen saturation Persistent pulmonary hypertension
Growth Parameters (SD) At 15months: OFC 41 cm (4.17SD) Weight 7.5 kg (2.46 SD) Height 72.5 cm (2.29 SD) At 21 months: OFC 43 cm (5.25 SD) Weight 10.45 kg (1.29 SD)Height 83.5 cm (0.31 SD) At 6 years: OFC50.4 cm (1.93 SD) Weight 26 kg (1.17 SD)
Microcephaly Yes Yes No
Fair skin (ethnic origin) Yes(Chinese) Yes (Scottish Caucasian) Yes (White British)
Hair Light hair color Very blonde Fair, not sparse, has a cowlick
Dysmorphic features Low set ears, flat nasal bridge, strabismus in the left eye, thin lip, polydactyly Thin upper lip; prominent lower lip; long smooth philtrum; small ears; brachycephaly. Low set ears; short philtrum; thin upper lip; high palate; prominent chin
Peripheral spasticity No Yes Yes
Truncal hypotonia Yes Yes No
Developmental progress Raised her head at 12 months but still unstably at 15months, still can't sit at age 15months Smiled at 4 months; Sat supported −8 months; Rolling −9 months; not walking at 3 Sat at 15 months Walked with rollator—age 4; Can't walk unaided at age 14 years
Speech impairment Makes some noises but no words. Makes lots of noises but no words. Single words at age 14 years
Visual defect Strabismus and retinal detachment of left eye Strabismus and hypermetropia, None

Because of her abnormal features (light hair color, fair skin, low ear position, flat nose, strabismus in the left eye, thin lips), microcephaly, hypotonia, development delay, retinal detachment, and polydactyly. Karyotype examination and the whole-exome sequencing were arranged for the patient, and her parents also did the whole-exome sequencing, because the patient's brother was healthy, he didn't take genetic test. Karyotype of the patients was normal, and a mutation c.1603C > T, p.R535X (gene position: CHR3: 41275708-41275708) was on exon 10 of chromosome 3, resulting in the loss of CTNNB1 gene function. The parents do not have the same gene mutation, then the child is identified as a de novo mutation (Figures 2, 3).

Figure 2.

Figure 2

DNA electrophoregram with the c.1603C > T,p.R535X mutation in exon 10 of CTNNB 1. 9Y2415:patient; 9Y2415FUVO:father; 9Y2415MUVO:mother.

Figure 3.

Figure 3

Pedigree of the family.

According to the clinical manifestations and gene mutation, the child was diagnosed as NEDSDV, and rehabilitation training was recommended. After 4 months of rehabilitation training, the child can raise her head steadily, but unable to sit, however, there was no significant improvement in language.

Discussion

In this study, we present a 15-month-old Chinese girl with a complex phenotype, which included dysmorphic features (light hair color, fair skin, low set ears, flat nasal bridge, strabismus in the left eye, thin lip), microcephaly, hypotonia, development delay, retinal detachment, and polydactyly. WES of the patient revealed a de novo heterozygous nonsense mutation in exon 10 of the CTNNB1 gene (c.1603C > T, p.R535X). This mutation had been reported in only two patients (2). All three patients had serious development delays, especially speech impairment. However, there were still some differences in the phenotype. The polydactyly and retinal detachment reported in our case has not been seen in the two cases previously reported.

CTNNB1 gene is located on 3q22.1 and encodes β–Catenin protein. Its mutation is related to many diseases, such as a tumor, autism, and so on. In 2012, Joep de ligt et al. reported for the first time that three patients with intellectual disability had CTNNB1 gene mutation, and their common phenotypes were: severe intellectual disability, absent or very limited speech, microcephaly, and spasticity with a severely impaired ability to walk. So far, 33 cases in the world have been reported. In 2017, the first case from Asian was reported (8), and as far as we knew, our case was the third case of the Asian population suffering from CTNNB1 mutation related neurodevelopmental disorders.

The patient we reported was similar to the previous reports, but the polydactyly was not reported in the previous cases, and retinal detachment was also rare in the previous case reports, only two cases in the Asian population reported with retinal detachment (8, 10). However, the mutations of the CTNNB1 were different from each other among the three patients. Previous studies have shown that heterozygous mutations in CTNNB1 can cause non-syndromic familial exudative vitreoretinopathy(FEVR) and that FEVR was part of the CTNNB1 haploinsufficiency phenotype (12), but the retinal detachment was only reported in the Asian population. Whether retinal detachment occurs in the Asian population is related to the genetic basis of the population, or because of the bias of too few reported cases, it needs to be further studied. Our patient expresses polydactyly, a unique symptom that has not been seen among other reported patients with CTNNB1 mutation. Its occurrence may be related to the abnormal Wnt / β signal pathway caused by CTNNB1 mutation. It has been found that mutation mice with polydactyly showed general de-regulated high levels of canonical Wnt/b-catenin signaling, it hypothesized that these Wnt/b-catenin signaling defects may contribute to the high proliferation rates in organ (13).

To date, 34 cases [one our case and 33 cases reported before (2, 511)] were reported. It appears to be a significant gender bias in those affected by inactivating CTNNB1 mutations(22 females,12 males). Although this is a small sample from which to infer such a finding and that may become more obvious as more cases are identified. Thirty-three lost-function mutations of CTNNB1 have been reported in the 34 patients, 19 nonsense mutations, nine frameshift mutations, three splice mutations, two complete gene deletions. The mutants were distributed in exons 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, and introns 5, 7, and 10. Among the 34 patients, the mutations of 33 patients were de novo, while one patient inherited the mutation (c.734+1G>A) from her mother who had similar but slighter clinical manifestations (10). The mechanism of CTNNB1 mutation leading to neurodevelopmental delay is not clear, but animal experiment identified that β-catenin loss could result in severe learning impairments, upregulation of γ-catenin (a partial functional homolog, whose neural-specific role is poorly defined) and reductions in synaptic adhesion and scaffold proteins which may affect brain development and function (14). Because of poor understanding of the molecular mechanisms of the disease, therapeutic strategies are limited. Most of the patients just were given rehabilitation training and symptomatic treatment. The progress is very poor, all patients suffered severe intellectual disability and can't live by themselves.

In conclusion, our study reported a heterozygous nonsense mutation in the CTNNB1 gene (c.1603C > T, p.R535X) in a Chinese family with neurodevelopment disorder, retinal detachment, and polydactyly. As far as we know, this is the third case reported in the Asian population and with a special retinal detachment which was only be reported in the Asian population, and we also found that polydactyly may be a new feature of CTNNB1 mutation. This report not only helps to expand the clinical phenotype spectrum of the CTNNB1 mutation but also prompts a new insight into genetic diagnosis in patients with a neurodevelopmental disorder, retinal detachment, and polydactyly.

Limitations and Strengths

We presented the clinical phenotype and genetic variation of a case with de novo CTNNB1 Nonsense Mutation, and firstly reported the phenotype of polydactyly in the CTNNB1 mutation. However, there were still some deficiencies, because of insufficient follow-up time, the development and prognosis of the case were unknown.

Data Availability Statement

All datasets presented in this study are included in the article/ supplementary material.

Ethics Statement

Written informed consent was obtained from the mother of the child for the publication of any potentially identifiable images or data included in this article.

Author Contributions

ZK contributed to the acquisition, analysis of data, and writing the first draft. YC contributed to the conception of the work and revised the paper. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We would like to thank the patient and parents for their cooperation and consent to this study.

References

  • 1.Dong F, Jiang J, Mcsweeney C, Zou D, Liu L. Deletion of CTNNB1 in inhibitory circuitry contributes to autism-associated behavioral defects. Hum Mol Genet. (2016) 25:2738–51. 10.1093/hmg/ddw131 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kharbanda M, Pilz DT, Tomkins S, Chandler K, Saggar A, Mckay V, et al. Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals. Eur J Med Genet. (2017) 60:130–5. 10.1016/j.ejmg.2016.11.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Paul J, Converse . CATENIN. BETA-1; CTNNB1. Retrieved August 16 2020, (2017). Available online at: https://omim.org/entry/116806?search=116806&highlight=116806 (accessed June 22, 2020).
  • 4.Marla JF, O'Neill. Neurodevelopmental disorder with spastic diplegia and visual defects; NEDSDV (2017). Available online at: https://omim.org/entry/615075 (accessed August 16, 2020).
  • 5.de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med. (2012) 367:1921–9. 10.1056/NEJMoa1206524 [DOI] [PubMed] [Google Scholar]
  • 6.Dubruc E, Putoux A, Labalme A, Rougeot C, Sanlaville D, Edery P, et al. A new intellectual disability syndrome caused by CTNNB1 Haploinsufficiency. Am J Med Genet A. (2014) 164A:1571–5. 10.1002/ajmg.a.36484 [DOI] [PubMed] [Google Scholar]
  • 7.Kuechler A, Willemsen MH, Albrecht B, Bacino CA, Bartholomew DW, Bokhoven H, et al. De novo mutations in beta - catenin (CTNNB1) appear to be a frequent cause of intellectual disability : expanding the mutational and clinical spectrum. Hum Genet. (2015) 134:97–109. 10.1007/s00439-014-1498-1 [DOI] [PubMed] [Google Scholar]
  • 8.Li N, Xu Y, Li G, Yu T, Yao R, Wang X, et al. Exome sequencing identifies a de novo mutation of CTNNB1 gene in a patient mainly presented with retinal detachment, lens and vitreous opacities, microcephaly, and developmental delay. Medicine (Baltimore). (2017) 96:e6914. 10.1097/MD.0000000000006914 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Tucci V, Kleefstra T, Hardy A, Heise I, Maggi S, Willemsen MH, et al. Dominant β -catenin mutations cause intellectual disability with recognizable syndromic features. J Clin Invest. (2014) 124:1468–82. 10.1172/JCI70372.1468 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wang H, Zhao Y, Yang L. Identification of a novel splice mutation in CTNNB1 gene in a Chinese family with both severe intellectual disability and serious visual defects. Neurol Sci. (2019) 40:1701–4. 10.1007/s10072-019-03823-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Winczewska-wiktor A, Badura-stronka M, Monies-nowicka A, Nowicki MM, Steinborn B, Latos-biele A, et al. A de novo CTNNB1 nonsense mutation associated with syndromic atypical hyperekplexia, microcephaly and intellectual disability : a case report. BMC Neurol. (2016) 16:35. 10.1186/s12883-016-0554-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Panagiotou ES, Soriano CS, Poulter JA, Lord EC, Dzulova D, Kondo H, et al. Defects in the Cell Signaling Mediator b -Catenin Cause the Retinal Vascular Condition FEVR. Am J Hum Genet. (2017) 100:960–8. 10.1016/j.ajhg.2017.05.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wheway G, Abdelhamed Z, Natarajan S, Toomes C, Inglehearn C, Johnson CA. Aberrant Wnt signalling and cellular over-proliferation in a novel mouse model of Meckel – Gruber syndrome. Dev Biol. (2013) 377:55–66. 10.1016/j.ydbio.2013.02.015 [DOI] [PubMed] [Google Scholar]
  • 14.Wickham RJ, Alexander JM, Eden LW, Valencia-yang M, Llamas J, Aubrey JR, et al. Learning impairments and molecular changes in the brain caused by β -catenin loss. Hum Mol Genet. (2019) 28:2965–75. 10.1093/hmg/ddz115 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All datasets presented in this study are included in the article/ supplementary material.


Articles from Frontiers in Pediatrics are provided here courtesy of Frontiers Media SA

RESOURCES